scispace - formally typeset
Open AccessJournal ArticleDOI

Magnetic resonance imaging in acute ischemic stroke treatment

Reads0
Chats0
TLDR
Understanding the clinical implication of various useful MRI findings and comprehensively incorporating those variables into therapeutic decision-making may be a more reasonable approach for expanding the indication of acute stroke thrombolysis.
Abstract
Although intravenous administration of tissue plasminogen activator is the only proven treatment after acute ischemic stroke, there is always a concern of hemorrhagic risk after thrombolysis. Therefore, selection of patients with potential benefits in overcoming potential harms of thrombolysis is of great importance. Despite the practical issues in using magnetic resonance imaging (MRI) for acute stroke treatment, multimodal MRI can provide useful information for accurate diagnosis of stroke, evaluation of the risks and benefits of thrombolysis, and prediction of outcomes. For example, the high sensitivity and specificity of diffusion-weighted image (DWI) can help distinguish acute ischemic stroke from stroke-mimics. Additionally, the lesion mismatch between perfusion-weighted image (PWI) and DWI is thought to represent potential salvageable tissue by reperfusion therapy. However, the optimal threshold to discriminate between benign oligemic areas and the penumbra is still debatable. Signal changes of fluid-attenuated inversion recovery image within DWI lesions may be a surrogate marker for ischemic lesion age and might indicate risks of hemorrhage after thrombolysis. Clot sign on gradient echo image may reflect the nature of clot, and their location, length and morphology may provide predictive information on recanalization by reperfusion therapy. However, previous clinical trials which solely or mainly relied on perfusion-diffusion mismatch for patient selection, failed to show benefits of MRI-based thrombolysis. Therefore, understanding the clinical implication of various useful MRI findings and comprehensively incorporating those variables into therapeutic decision-making may be a more reasonable approach for expanding the indication of acute stroke thrombolysis.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Deep into the Brain: Artificial Intelligence in Stroke Imaging.

TL;DR: A glimpse at the use of AI in stroke imaging is offered, specifically focusing on its technical principles, clinical application, and future perspectives.
Journal ArticleDOI

Machine Learning Approach to Identify Stroke Within 4.5 Hours.

TL;DR: Machine learning techniques analyzing diffusion-weighted imaging and fluid-attenuated inversion recovery magnetic resonance imaging to identify patients within the recommended time window for thrombolysis were investigated.
Journal ArticleDOI

Acute Brain Lesions on Magnetic Resonance Imaging and Delayed Neurological Sequelae in Carbon Monoxide Poisoning.

TL;DR: The presence of acute brain lesions was significantly associated with the development of delayed neurological sequelae and diffusion-weighted imaging during the acute phase of carbon monoxide poisoning may help identify patients at risk of developing these debilitating sequelae.
References
More filters
Journal ArticleDOI

Thrombolysis with Alteplase 3 to 4.5 Hours After Acute Ischemic Stroke

TL;DR: As compared with placebo, intravenous alteplase administered between 3 and 4.5 hours after the onset of symptoms significantly improved clinical outcomes in patients with acute ischemic stroke; altePlase was more frequently associated with symptomatic intracranial hemorrhage.
Journal ArticleDOI

Pathobiology of ischaemic stroke: an integrated view

TL;DR: This article provides a framework that can be used to generate testable hypotheses and treatment strategies that are linked to the appearance of specific pathophysiological events within the ischaemic brain.
Related Papers (5)